scholarly journals CRT-500 Impact of First and Second Generation Drug-Eluting Stents on Bare Metal Stent Failure

2014 ◽  
Vol 7 (2) ◽  
pp. S45
Author(s):  
Hideaki Ota ◽  
Marco A. Magalhaes ◽  
Al Fazir Omar ◽  
Joshua P. Loh ◽  
Lakshmana K. Pendyala ◽  
...  
Keyword(s):  
Second Generation ◽  
Bare Metal Stent ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Metal Stent ◽  
Drug Eluting ◽  
First And Second Generation

Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents

2013 ◽  
Vol 24 (2) ◽  
pp. 165-170 ◽  
Author(s):  
Mohammad Almalla ◽  
Jörg W. Schröder ◽  
Verena Pross ◽  
Nikolaus Marx ◽  
Rainer Hoffmann
Keyword(s):  
First Generation ◽  
Second Generation ◽  
Bare Metal Stent ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Metal Stent ◽  
Stent Restenosis ◽  
Drug Eluting

scholarly journals Long-term adverse outcomes associated with drug-eluting stents and bare-metal stent in patients with small coronary artery disease: a systematic review and meta-analysis

2018 ◽  
Vol 15 (1) ◽  
pp. 1-7
Author(s):  
Nabin Chaudhary ◽  
Pravesh Kumar Bundhun ◽  
Sujan Shrestha ◽  
He Yan
Keyword(s):  
Coronary Artery Disease ◽  
Meta Analysis ◽  
Bare Metal Stent ◽  
Adverse Outcomes ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Metal Stent ◽  
Drug Eluting ◽  
Artery Disease

Objective: The main purpose of this meta-analysis was to compare the long-term adverse outcomes associated with drug-eluting stents (DES) and bare-metal stent (BMS) in patients with small coronary artery disease (CAD).Method: Randomized Controlled Trials (RCTs) and observational studies comparing the adverse outcomes such as mortality, major adverse cardiovascular events (MACE), myocardial infarction (MI), stent thrombosis (ST), target lesion revascularization (TLR), target vessel revascularization (TVR), and restenosis in small CAD patients receiving DES and BMS were searched from Embase, PubMed, and Cochrane Library databases. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated and the pooled analyses were performed with RevMan 5.3.Result: A total number of 4,106 patients with small CAD (2,123 patients received DES and 1,983 patients received BMS) have been included in this meta-analysis. Pool-analysis demonstrated that the risk of mortality, MACE, MI, ST, TLR, TVR, and restenosis were significantly lower in DES group, with OR 0.77(95%CI 0.59-0.99, P=0.04), 0.48(95%CI 0.41-0.56, P<0.00001), 0.74(95%CI 0.55-0.98, P=0.04), 0.51(95%CI: 0.26-0.98, P=0.04), 0.24(95%CI: 0.16-0.37, P<0.00001), 0.47(95%CI: 0.38-0.59, P<0.00001), and 0.24 (95%CI 0.14-0.43, P<0.00001), respectively.Conclusion: Compared with BMS, DES had lower rates of adverse clinical outcomes, and restenosis during long-term follow-up.Nepalese Heart Journal 2018; 15(1): 1-7

scholarly journals 0234: Drug-eluting stents versus bare-metal stent in large coronary arteries

2016 ◽  
Vol 8 (1) ◽  
pp. 11
Author(s):  
Majed Hassine ◽  
Mehdi Boussada ◽  
Mejdi Ben Massoud ◽  
Marouen Mahjoub ◽  
Zohra Dridi ◽  
...  
Keyword(s):  
Coronary Arteries ◽  
Bare Metal Stent ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Metal Stent ◽  
Drug Eluting ◽  
Large Coronary Arteries
Sign in / Sign up

Export Citation Format

Share Document